European Archives - Page 505 of 1350 - European Medical Journal

Ultrasonography Unreliable for Diagnosing Endometrial Cancer in Black Females

Concerns about the reliability of transvaginal ultrasonography in diagnosing endometrial cancer among Black females have been raised in a recent study.

Ablation Most Cost-Effective Liver Cancer Treatment

Ablation has been shown to be the most cost-effective treatment for hepatocellular carcinoma in a recently published study.

EULAR 2024 Interview: Xenofon Baraliakos

We have grown as a department, have broadened our fields of research to other diseases beyond spondyloarthritis and psoriatic arthritis…

New-Onset Anxiety Linked to Increased Parkinson’s Disease Risk

Recent research highlights a significant link between anxiety and the risk of developing Parkinson’s disease in older adults.

Discontinuing Anticoagulants Increases Stroke Risk in Patients with Atrial Fibrillation

Findings from a recent study demonstrated that discontinuing oral anticoagulation significantly increases the risk of recurrent ischemic stroke in patients with atrial fibrillation.

a woman working with a neonatal unit

Tiny Miracles: Innovating Neonatal Care

Focused on the building of relationships with the families of premature babies, this episode discusses the challenges and opportunities in neonatal medical technology development.

Immunoglobulin Replacement Therapy Reduces Infections in Patients with Haematological Malignancies

A recent study has found that immunoglobulin replacement therapy significantly decreases the incidence of infections and antimicrobial use in patients with chronic lymphocytic leukemia.

The latest edition of EMJ Nephrology

Watch our promotional video for the latest issue of EMJ Nephrology, featuring coverage of ERA 2024 and the newest advancements in kidney care.

EMJ Nephrology 12.1 2024

In our latest issue of EMJ Nephrology, discover the latest in the field, featuring developments in antibody-mediated rejection…

SGLT2 Computational Structural Studies Investigating Polypharmacy

Widespread use of SLGT2 inhibitors (SGLT2i) is likely given recent recommendations for their use in chronic kidney disease and heart…